Chinese President Xi Jinping blamed mass protests in Chinese cities on youth frustrated by years of the COVID-19 pandemic, but said the now dominant Omicron variant of the virus paved the way for fewer restrictions, European Union officials said.
Mpox is expected to no longer be considered a public health emergency in the United States from Feb. 1, 2023, the U.S. health department said on Friday.
Protests in China against the world's toughest COVID-19 curbs are dying down because they have had an effect, U.S. Deputy Secretary of State Wendy Sherman said on Friday, as Beijing further eased testing requirements and quarantine rules.
Lapses in strategies to tackle COVID-19 this year continue to create the perfect conditions for a deadly new variant to emerge, as parts of China witness a rise in infections, the head of the World Health Organization said on Friday.
Uganda has discharged its last known Ebola patient from hospital, a senior health official said on Friday, raising hopes that an outbreak which has killed at least 56 people could be coming to an end.
Pfizer Inc is investing more than $2.5 billion at its drug making plants in Belgium and Ireland, gearing up to launch new products it hopes can replace lost revenue as patents expire and COVID-19 vaccine sales decline.
The near year-long infant formula shortage in the United States that prompted the intervention of the White House is likely to "persist" until spring, according to Reckitt Benckiser, the maker of what is now the biggest brand in the market, Enfamil.
U.S. drugmaker Merck & Co hopes to patent a new formulation of its $20 billion cancer immunotherapy Keytruda that can be injected under the skin, allowing it to protect its best-selling drug from competition expected as soon as 2028.
Opinions about Xi Jinping's signature "zero-COVID" policy vary wildly across China. The debate, which has ignited several anti-lockdown protests, illustrates the difficulties facing the government in relaxing the world's most rigid COVID rules while heading off national discontent.
Further easing of COVID-19 testing requirements and quarantine rules in some Chinese cities was met with a mix of relief and worry on Friday, as hundreds of millions await an expected shift in national virus policies after widespread social unrest.
